Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells

Cancer Epidemiology

Volumn 37, Issue 4, 2013, Pages 512-517

  Parajuli, Bidur ^a   Lee, Hyun Gyo ^a   Kwon, Sang Hoon ^a   Cha, Soon Do ^a   Shin, So Jin ^a   Lee, Gun Ho ^b   Bae, Insoo ^c   Cho, Chi Heum ^a  

^a Keimyung University   (South Korea)

^b CHA University   (South Korea)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Akt; Apoptosis; Cisplatin resistance; Ovarian cancer; Salinomycin

Indexed keywords

CASPASE 3; CISPLATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SALINOMYCIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; FLOW CYTOMETRY; GROWTH INHIBITION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; NF-KAPPA B; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PYRANS;

EID: 84878952285     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.02.008     Document Type: Article

References (25)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics. CA Cancer J Clin 2006, 56:106-130.
2. Gupta P.B., Onder T.T., Jiang G., Kuper Wasser C.C., Weinberg R.A., Lander E.S. Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell 2009, 138:645-659.
3. Miyazaki Y., Shibuya M., Sugawara H., Kawaguchi O., Hirsoe C. Salinomycin, a new polyether antibiotic. J Antibiot 1974, 27:814-821.
4. Mahmoudi N., De Julian-Ortiz J.V., Ciceron L., Galvez J., Mazier D., Danis M., et al. Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening. J Antimicrob Chemother 2006, 57:489-497.
5. Danforth H.D., Ruff M.D., Reid W.M., Miller R.L. Anticoccidial activity of salinomycin in battery raised broiler chichens. Poult Sci 1977, 56:926-932.
6. Mitani M., Yamanishi T., Miyazaki Y. Salinomycin: a new monovalent cation ionophore. Biochem Biophys Res Commun 1975, 27:1231-1236.
7. Fuchs D., Heinold A., OPelz G., Daniel V., Naujokat C. Salinomicin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem Biophys Res Commun 2009, 390:734-749.
8. Zhang Y., Zhang H., Wang X., Wang J., Zhang X., Zhang Q. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials 2012, 33:679-691.
9. Lu D., Choi M.Y., Yu J., Castro J.E., Kipps T.J., Carson D.A. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc Nat Acad of Sci USA 2011, 108:13253-13257.
10. Riccioni R., Dupuis M.L., Bernabei M., Petrucci E., Pasquini L., Mariani G., et al. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol Dis 2010, 45:86-92.
11. Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L., et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003, 17:590-603.
12. Martelli A.M., Cocco L., Capitani S., Miscia S., Papa S., Manzoli F.A. Nuclear phosphatidyllinositol 3,4,5-triphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis. Eur J Histochem 2007, 51:125-131.
13. Zhang B., Wang X., Cai F., Chen W., Loesh U., Bitzer J., et al. Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK. Tumour Biol 2012, 33:1855-1862.
14. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the tranacription factor NF-κB. J Clin Invest 2001, 107:241-246.
15. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
16. Sommermann T.G., O'Neill K., Plas D.R., Cahir-McFarland E. IKKβ and NF-κB transcription govern lymphoma cell survival through Akt-induced plasma membrane trafficking of GLUT 1. Cancer Res 2011, 71:7291-7300.
17. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J., Baldwin A.S., Mayo M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2002, 20:1626-1638.
18. Oki K., Baba H., Tokunaga E., Nakamura T., Ueda N., Futatsugi M., et al. Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int J Cancer 2005, 117:376-380.
19. Shin J.Y., Kim J.O., Lee S.K., Chae H.S., Kang J.H. LY294002 may overcome 5-FU resistance via down-regulation of activated p-Akt in Epstein-Barr virus-positive gastric cancer cells. BMC Cancer 2010, doi:10.1186/1471-2407-10-425.
20. Huang S., Robinson J.B., Deguzman A., Bucana C.D., Fidler I.J. Blockade of nuclear factor-KappaB signaling inhibits angiogenesis and tumorigenisity of ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 2000, 60:5334-5339.
21. Cilloni D., Messa F., Arruga F., Defilippi I., Morotti A., Messa E., et al. The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance. Leukemia 2006, 20:61-67.
22. Kuo S.Z., Blair K.J., Ahimy E., Kiang A., Abhold E., Fan J.B., et al. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt. BMC Cancer 2012, 12:556.
23. Fuchs D., Daniel V., Sadeghi M., Oopelz G., Naujokat C. Salinomcin induces apoptosis and overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 2010, 394:1098-1104.
24. Boehmerlen W., Endres M. Salinomycin induces calpain and cytochrome c-mediated neuronal cell death. Cell Death 2011, doi:10.1038/cddis.2011.46.
25. Dong T.T., Zhou H.M., Wang L.L., Feng B., Lv B., Zheng M.H. Salinomycin selectively targets CD133+ cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 2011, 18:1797-1804.